Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 285-561-1 | CAS number: 85117-09-5 Mixtures of chemical substances produced by burning (below 1200°C) natural variants of limestone or chalk containing from 10 to 20%, or more, of clayey or siliceous materials which are predominantly SiO2, Al2O3 and iron oxide. Consist primarily of 2CaOsb.2, Ca(OH)2, CaO and 2CaOsb.2O3. 3CaO.2SiO2, 4CaOsb.2O3. Fe2O3, 2CaOsb.2O3sb.2, CaCO3 and SiO2 may also be included.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Well-documented publication. When administered via the oral route, lime (chemical) hydraulic, namely the main constituent calcium hydroxide, will be neutralised in the GI tract. Other main constituents or major impurities (calcium carbonate, calcium silicate, calcined clay minerals) are not identified as hazardous substances and therefore considered not to be of toxicological concern. Therefore, calcium will remain as the only substance of potential toxicological relevance. Under physiological conditions the hydroxyl-ions released from the test substance calcium oxide are neutralised e.g. in the GI tract and are therefore not relevant for consideration of systemic toxicity. Therefore the objective of the study was the evaluation of any effects of calcium. In view of the limited relevance of the anionic counter-ions discussed here, calcium released both from calcium oxide and lime (chemical) hydraulic can be considered as equivalent, and the results of the study can be used by read-across. The study allows the derivation of a NOAEL value for effects of Ca regarding developmental toxicity in rats and mice.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 974
- Report date:
- 1974
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Calcium oxide
- EC Number:
- 215-138-9
- EC Name:
- Calcium oxide
- Cas Number:
- 1305-78-8
- Molecular formula:
- CaO
- IUPAC Name:
- Calcium oxide
- Details on test material:
- - Name of test material (as cited in study report): FDA 73-41 (calcium oxide)
- Physical state: solid
No further details are given.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Housing: Mice were housed in groups in disposable plastic cages.
- Diet: ad libitum
- Water: ad libitum; tap water
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23-27
- Humidity (%): 64-78
No further details are given.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- no detailed data given
- Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- no detailed data given
- Details on mating procedure:
- The female mice were mated with young adult males.
- Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: 1/1; one male was not permitted to impregnate more than one female per group.
- Length of cohabitation: no data
- Proof of pregnancy: vaginal plug referred to as day 0 of pregnancy
No further details are given. - Duration of treatment / exposure:
- Day 6 to 15 of gestation.
- Frequency of treatment:
- Once daily.
- Duration of test:
- Until day 17 of pregnancy.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
4.4 mg/kg
Basis:
nominal in water
- Remarks:
- Doses / Concentrations:
20.4 mg/kg
Basis:
nominal in water
- Remarks:
- Doses / Concentrations:
94.8 mg/kg
Basis:
nominal in water
- Remarks:
- Doses / Concentrations:
440 mg/kg
Basis:
nominal in water
- No. of animals per sex per dose:
- mated: 25 to 26 mice
pregnant: 17 to 21 mice - Control animals:
- yes
- yes, sham-exposed
- Details on study design:
- no data available
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: All animals were observed daily for appearance and behaviour.
BODY WEIGHT: Yes
- Time schedule for examinations: Average body weight was determined on days 0, 6, 11, 15 and 17
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes; however, compound intake occurred by gavage.
- Time schedule: All animals were observed daily with particular attention to food consumption and weight.
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data; not applicable
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 17
- Organs examined: The urogential tract of each dam was examined in detail for anatomical normality. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - External examinations: Yes
- Soft tissue examinations: Yes
- Skeletal examinations: Yes
- Head examinations: Yes - Statistics:
- no data given
- Indices:
- no data given
- Historical control data:
- no data given
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
Administration of up to 440 mg/kg bw/d of CaO to pregnant mice for 10 consecutive days had no clearly discernible effect on maternal survival.
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- >= 440 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- >= 315 mg/kg bw/day
- Based on:
- element
- Remarks:
- Ca
- Basis for effect level:
- other: developmental toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- >= 440 mg/kg bw/day
- Basis for effect level:
- other: maternal toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- >= 315 mg/kg bw/day
- Based on:
- element
- Remarks:
- Ca
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
Administration of up to 440 mg/kg bw/d of CaO (= 315 mg Ca/kg bw/d) to pregnant mice for 10 consecutive days had no clearly discernible effect on foetal survival.
The number of abnormalities seen in either soft or skeletal tissues of test groups did not differ from the number occuring spontaneously in sham-treated controls.
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Administration of up to 440 mg/kg bw/d of the test material to pregnant mice for 10 consecutive days had no clearly discernible effect on nidation or on maternal or foetal survival. The number of abnormalities seen in either soft or skeletal tissues of test groups did not differ from the number occuring spontaneously in sham-treated controls.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.